Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cremer Oleo is a prominent global supplier and manufacturer of oleochemical products, catering to the pharmaceutical, cosmetic, and food industries. As a division of the Peter Cremer Holding, the company specializes in processing vegetable oils into high-quality derivatives such as fatty acids, fatty alcohols, and glycerine. In the healthcare sector, Cremer Oleo is recognized for its range of pharmaceutical-grade excipients, including medium-chain triglycerides (MCTs) and specialized esters used in topical, oral, and parenteral drug formulations. The company maintains a robust global presence with production sites and distribution hubs across Europe, Asia, and the Americas. Their operations are characterized by a commitment to sustainability and adherence to stringent quality standards, including Good Manufacturing Practice (GMP) for pharmaceutical ingredients.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CREMER OLEO.